ArticleJournal of virology2024

Efficacy of late-onset antiviral treatment in immunocompromised hosts with persistent SARS-CoV-2 infection.

Carolin M Lieber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.